Skip to main navigation Skip to search Skip to main content

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

  • Marc Bourlière
  • , Stuart C Gordon
  • , Steven L Flamm
  • , Curtis L Cooper
  • , Alnoor Ramji
  • , Myron Tong
  • , Natarajan Ravendhran
  • , John M Vierling
  • , Tram T Tran
  • , Stephen Pianko
  • , Meena B Bansal
  • , Victor de Lédinghen
  • , Robert H Hyland
  • , Luisa M Stamm
  • , Hadas Dvory-Sobol
  • , Evguenia Svarovskaia
  • , Jie Zhang
  • , K C Huang
  • , G Mani Subramanian
  • , Diana M Brainard
    • John G McHutchison, Elizabeth C Verna, Peter Buggisch, Charles S Landis, Ziad H Younes, Michael P Curry, Simone I Strasser, Eugene R Schiff, K Rajender Reddy, Michael P Manns, Kris V Kowdley, Stefan Zeuzem

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science